Limited visibility of post-resection muscle-invasive bladder cancer (MIBC) on CT hinders radiotherapy dose escalation of the residual tumour. Diffusion-weighted magnetic resonance imaging (DW-MRI) visualizes areas of high tumour burden and is increasingly used within diagnosis and as a biomarker for cancer.